Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 30, 2021

SELL
$259.0 - $414.71 $1,554 - $2,488
-6 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$264.77 - $305.71 $2,912 - $3,362
-11 Reduced 64.71%
6 $2,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $2,586 - $3,425
-10 Reduced 37.04%
17 $5,000
Q1 2020

May 06, 2020

BUY
$268.85 - $341.04 $5,645 - $7,161
21 Added 350.0%
27 $9,000
Q4 2019

Jan 29, 2020

SELL
$220.06 - $304.07 $19,585 - $27,062
-89 Reduced 93.68%
6 $2,000
Q3 2019

Oct 31, 2019

BUY
$217.44 - $243.88 $6,740 - $7,560
31 Added 48.44%
95 $22,000
Q2 2019

Aug 06, 2019

BUY
$219.29 - $241.72 $12,718 - $14,019
58 Added 966.67%
64 $15,000
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $12,569 - $19,659
-58 Reduced 90.63%
6 $1,000
Q4 2018

Jan 18, 2019

SELL
$278.5 - $352.75 $41,775 - $52,912
-150 Reduced 70.09%
64 $19,000
Q3 2018

Nov 07, 2018

BUY
$293.51 - $383.83 $61,050 - $79,836
208 Added 3466.67%
214 $76,000
Q2 2017

Aug 07, 2017

BUY
N/A
6
6 $2,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Fusion Family Wealth LLC Portfolio

Follow Fusion Family Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fusion Family Wealth LLC with notifications on news.